Investing.com -- William Blair remains optimistic on Tesla (NASDAQ: TSLA) despite recent setbacks, forecasting that shares ...

Tesla shares fell more than 4% on Wednesday morning, threatening the EV maker's blistering rebound out of a prolonged slump.

Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...

In a noteworthy financial move, William Blair Investment Management LLC has escalated its holdings in Live Nation Entertainment, Inc. (NYSE: LYV) by an impressive 18.7% in the fourth quarter, as ...

Stock analysts at William Blair increased their Q1 2025 earnings estimates for Boeing in a research report issued on ...

In a report released today, Sami Corwin from William Blair reiterated a Buy rating on Neurogene (NGNE – Research Report). The company’s shares ...

Fintel reports that on March 24, 2025, William Blair downgraded their outlook for AZEK (NYSE:AZEK) from Outperform to Market ...

William Blair restated their outperform rating on shares of Neurogene (NASDAQ:NGNE – Free Report) in a report published on ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.

In a report released today, Andy Hsieh from William Blair reiterated a Hold rating on Terns Pharmaceuticals (TERN – Research Report). The ...

The bank has added Affirm as an option, after adding the fintech's rival Klarna to its merchant network in February.

The Progressive Corporation (NYSE:PGR) is an insurance holding company that operates through various subsidiaries and ...